MTVA
MTVA clinical trials: MetaVia Inc.
Every trial on ClinicalTrials.gov where MetaVia Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 15
- Trials linked
- 15
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MTVA on the catalyst calendar · MTVA registry changes
- Primary completion Nov 9, 2026Sponsor estimatePhase 1NCT06252220First in Human Study in Subjects With Obesity, But Otherwise HealthyNeuroBo Pharmaceuticals Inc. · ObesityRecruitingMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 16, 2022ActualPhase 2/Phase 3NCT04603924Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) PatientsNeuroBo Pharmaceuticals Inc. · COVID-19CompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 13, 2021ActualPhase 1NCT04705415A Single and Multiple Ascending Dose Study of Niclosamide in Healthy VolunteersNeuroBo Pharmaceuticals Inc. · HealthyCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 24, 2024ActualPhase 2NCT06054815Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASHNeuroBo Pharmaceuticals Inc. · NON-ALCOHOLIC STEATOHEPATITISCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 11, 2018ActualPhase 2NCT02944383A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe HypertriglyceridemiaNeuroBo Pharmaceuticals Inc. · Severe HypertriglyceridemiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2017ActualPhase 2NCT02722408Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)NeuroBo Pharmaceuticals Inc. · HypercholesteremiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2017ActualPhase 2NCT02634151A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity StatinsNeuroBo Pharmaceuticals Inc. · HypercholesteremiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2003ActualPhase 2NCT02591836Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With AtorvastatinNeuroBo Pharmaceuticals Inc. · HypercholesterolemiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2002ActualPhase 1NCT02587416Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy VolunteersNeuroBo Pharmaceuticals Inc. · HypercholesteremiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2000ActualPhase 1NCT02587390Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy VolunteersNeuroBo Pharmaceuticals Inc. · HypercholesterolemiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 1999ActualPhase 1NCT02587364Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy VolunteersNeuroBo Pharmaceuticals Inc. · HypercholesterolemiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2001ActualPhase 2NCT02586168The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic SubjectsNeuroBo Pharmaceuticals Inc. · Insulin SensitivityCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2001ActualPhase 2NCT02585869Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated TriglyceridesNeuroBo Pharmaceuticals Inc. · HypercholesterolemiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2002ActualPhase 2NCT02571257Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin TherapyNeuroBo Pharmaceuticals Inc. · HypercholesterolemiaCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2015ActualPhase 2NCT01822925Study of DA-9801 to Treat Diabetic NeuropathyNeuroBo Pharmaceuticals Inc. · Diabetic NeuropathyCompletedMTVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 15 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner